Navigation Links
Evonik and Genedata Broaden Their Collaboration with the Genedata Selector Biotechnology Data Management Platform
Date:9/17/2013

Selector enterprise software, Evonik will also use Genedata scientific data analysis consulting services. Based on in-depth and extensive experience in the industrial biotechnology field, these value-added services help to eliminate resource bottlenecks, provide cost-effective support for strategically important projects, and deliver valuable results quickly and efficiently.

Addressing the complete life cycle of R&D projects – from early-stage feasibility studies to late-stage product development – Genedata scientific data analysis consulting delivers:

  • proprietary genome annotations, including gene calling and functional annotations up to the pathway level (for prokaryotes as well as eukaryotes);
  • production strain comparisons, including interpretations of biological effects of variants (e.g. on enzyme activities);
  • cellular signaling network reconstructions for proprietary strains, based on expression and regulatory sequence data;
  • biomarkers, based on omics, NGS, pathway, and functional annotation data; and
  • statistical expression analysis reports (e.g. of microarray or RNAseq data).

In the enterprise R&D environment, Genedata specialized IT services ensure server availability and infrastructure stability for high-performance server infrastructures. These services, which empower researchers to focus more on scientific discovery, include:

  • hosting and remote server maintenance;
  • software and database integration services; and
  • data migration and integration services, including public domain genome release monitoring.

“We are proud of our long-standing and successful partnership with Evonik, a world leader in specialty chemicals,” noted Dr. Othmar Pfannes, CEO of Genedata. “Their adoption of the Genedata Selector application suite, coupled with our scientific consulting and prof
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Genedata Screener Global User Group Meetings Will Examine Advancements in Plate-based Screening
2. Genedata Screener Extends Support for High-Throughput Thermofluor Assays
3. Genedata at ESACT Announces Expansion Into Biopharma Process Development
4. New Genedata Expressionist for Mass Spectrometry Showcases at 2013 ASMS
5. AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization
6. Genedata Biologics for Biopharma R&D at Ninth Annual PEGS
7. Genedata Screener 11 with Compound Combination Screening and Collaboration in the Cloud Announced at Bio-IT World 2013
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Genedata Expressionist for Mass Spectrometry Showcased at 2013 Biotherapeutics Analytical Summit
10. Ono Pharmaceutical Selects Genedata Expressionist for Mass Spectrometry
11. Genedata Biologics 3.0 Boosts Efficiency Through Standardization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ... , 3.75% Convertible Senior Notes due May 1, ... per $1,000 principal amount or approximately $5.72 per share, effective ... note is adjusted in connection with the regular quarterly dividend ... stockholders who own shares of PDL on March 5, 2015, the ...
(Date:3/4/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/nqxxt3/biomarkers ) ... report "Biomarkers - Technologies, Markets and Companies" ... report follows the broad definition of a biomarker ... and evaluated as an indicator of normal biological ... to a therapeutic intervention. Tests based on biomarkers ...
(Date:3/4/2015)... , March 4, 2015 AcelRx ... specialty pharmaceutical company focused on the development and ... acute and breakthrough pain, today announced that it ... results after market close on Monday, March 9th, ... call at 4:30 p.m. Eastern Time (1:30 p.m. ...
(Date:3/4/2015)... 4, 2015 Lancée ... Paris en décembre 2011, l,étude collaborative ... », qui compare   l es microsphères ... sorafénib dans le carcinome hépatocellulaire avancé, a recruté ... foie avancé   ; les résultats sont attendus ...
Breaking Biology Technology:PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 2AcelRx Pharmaceuticals to Hold Annual 2014 Financial Results Conference Call and Webcast on Monday, March 9th, 2015 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6
... ... today that it has entered into a multi-year, sole-source supply agreement with leading global ... infant formulas and milk-based Anmum™ Materna products for pregnant and nursing mothers. , ... Columbia, MD (Vocus) December ...
... , Collaboration to Create Optimized Antibodies Produces First Candidates ... ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... collaborative program between YM and the National Research ... YM,s IntelliMab(TM) technology, the program is designed to generate ...
... ... the country specifically established to treat adolescents and adults and is today the largest of ... registry. , ... 2009 -- The Hertz Family Foundation of Santa Monica has announced that total contributions now ...
Cached Biology Technology:Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3
(Date:2/18/2015)... Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... speaking at the following conferences, and invited investors to participate ... Boston, MA Tuesday, March 3, 2015 ... Investors Conference, Orlando, FL Wednesday, March ... Live Webcasts To access the live webcasts for these events, ...
(Date:2/12/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announced today ... DISTRIBUTED METHOD AND SYSTEM TO IMPROVE COLLABORATIVE SERVICES ... NXT-ID,s position in the emerging "Internet of Things" by ... multiple devices to collaborate with one another to improve ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
Breaking Biology News(10 mins):Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... Department of Energy's Lawrence Berkeley National Laboratory have ... of high-quality images of biological molecules from electron ... of experienced human analysts. , The new ... to greatly increase the speed and power of ...
... Doctors and scientists nationwide will today for the first time ... the search for genes that underlie a range of chronic ... other common diseases have been providing blood samples for research ... The University of Manchester that will allow more researchers than ...
... allowing for retrieval from different areas of the brain, depending ... at Baylor College of Medicine. , That is what Dr. ... BCM, theorizes, based on his most recent report on the ... flies is formed in a pair of neurons called the ...
Cached Biology News:Picking particles faster than one at a time 2Picking particles faster than one at a time 3Picking particles faster than one at a time 4Picking particles faster than one at a time 5'Dating agency' boosts hunt for disease genes 2Tracking the memory trace 2
Request Info...
... DNA Polymerase I from ... DNA polymerase. The enzyme also ... activities.1 The 5'?3' exonuclease activity ... nicks and gaps in the ...
Request Info...
... containing a clone of the human Topoisomerase II ... alters the topological state of nucleic acids by ... break which generates a separate DNA helix (1,2) ... passage mechanism, the enzyme can relax negatively or ...
Biology Products: